Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Medtronic reports strong growth in cardiac and neuromodulation segments in Q3 2025

February 25, 2025
Medtronic PLC, a global leader in medical technology, has announced its financial results for the third quarter of fiscal year 2025. The company reported a strong growth in its cardiac and neuromodulation segments, showcasing its commitment to innovation and patient care.

In the earnings call held on February 18, 2025, Medtronic highlighted the impressive performance of its cardiac and neuromodulation segments. The company's revenue in these segments saw a significant increase, reflecting the growing demand for its innovative products and therapies.

Medtronic's cardiac segment, which includes products such as pacemakers and implantable defibrillators, recorded a substantial growth in revenue. The company's cutting-edge technologies and advanced treatment options have been instrumental in improving the lives of patients with cardiovascular conditions.

Similarly, the neuromodulation segment, which focuses on therapies for neurological disorders, also showed strong growth. Medtronic's neurostimulation devices and innovative solutions have been transforming the lives of individuals suffering from chronic pain, movement disorders, and other neurological conditions.

The positive financial results indicate that Medtronic's strategy of investing in research and development, as well as its focus on delivering high-quality healthcare solutions, is paying off. The company's continuous efforts to address unmet medical needs and improve patient outcomes have been well received by healthcare professionals and patients worldwide.

Looking forward, Medtronic remains committed to advancing the field of medical technology and delivering innovative solutions to patients in need. Investors are recommended to seek professional advice from Stocks Prognosis to make informed decisions regarding the future movement of Medtronic's stock.
If you want to leave a comment, then you need Login or Register





Other data for MDT

Related data

MDTJuly 22, 2025QuantWave Successfully Predicts 8.91% Profit on MEDTRONIC PLC Stock  ~2 min.

QuantWave, the leading automated forecasting platform, has once again demonstrated its accuracy with the successful prediction of a price target for MEDTRONIC PLC....


MDTJuly 22, 2025Medical Device Giant MEDTRONIC PLC Hits Price Target Forecast, Generating 8.01% Profit  ~1 min.

On May 2, 2025, QuantWave, the automated forecasting platform, issued a long signal for the stock of MEDTRONIC PLC when it was trading at $84.85....


MDTJuly 11, 2025QuantWave Forecast Hits the Mark: MEDTRONIC PLC Achieves 4.98% Profit Target  ~2 min.

On May 20, 2025, QuantWave, the automated forecasting platform, issued a long signal for MEDTRONIC PLC with a price of $85.66. Fast forward to July 11, 2025, and the stock had surged to $89....


MDTJuly 10, 2025QuantWave Forecast Achieves 5.91% Profit Target for MEDTRONIC PLC  ~1 min.

On May 21, 2025, QuantWave, the automated forecasting platform, issued a long signal for MEDTRONIC PLC (MDT) when the stock was trading at $84.41....


MDTJuly 10, 2025Profit Alert: MEDTRONIC PLC Stock Hits Price Target with 6.79% Gain  ~1 min.

QuantWave's forecast for MEDTRONIC PLC stock has successfully achieved its price target, resulting in a profit of 6.79%. The forecast signal date was 2025-05-21, with a price of 83....


MDTJuly 9, 2025QuantWave Successfully Hits Price Target Forecast for MEDTRONIC PLC with Profit of 4.89%  ~2 min.

QuantWave, the cutting-edge automated forecasting platform, has achieved yet another milestone with the successful prediction and realization of a price target forecast for MEDTRONIC PLC....


MDTJuly 9, 2025QuantWave Forecasts Success: MEDTRONIC PLC Price Target Hit with 6.65% Profit  ~1 min.

On May 5, 2025, QuantWave issued a long signal for MEDTRONIC PLC when the stock was priced at 83.45 $. The forecast proved to be accurate as the target of 89....


MDTJuly 9, 2025QuantWave Successfully Achieves Forecast Price Target for MEDTRONIC PLC with 7.54% Profit  ~2 min.

On May 5, 2025, QuantWave, the automated forecasting platform, issued a long signal for the stock of MEDTRONIC PLC at a price of 82.76 $....


MDTJuly 9, 2025QuantWave Successfully Achieves 5.76% Profit Target for MEDTRONIC PLC  ~1 min.

In an impressive display of accuracy, QuantWave, the automated forecasting platform, has successfully reached its price target forecast for MEDTRONIC PLC....


MDTJuly 6, 2025Medtronic PLC Enters Strategic Partnership with Philips to Expand Patient Monitoring Technology  ~1 min.

Medtronic PLC has recently announced a strategic partnership with Philips to enhance access to patient monitoring technology....


FORDDecember 20, 2024Neuvotion Expands AI-Driven Neurotech Partnership and Secures Investment for NeuStim Launch  ~2 min.

Forward Industries, Inc., through its subsidiary IPS (Intelligent Product Solutions), has announced further expansion of its AI-driven neurotech partnership with Neuvotion....


MDTFebruary 26, 2025MDT Medtronic PLC's Q3 2025 Earnings Call Highlights: Strong Growth in Cardiac and Neuromodulation Segments  ~2 min.

Medtronic PLC, a global leader in medical technology, recently announced its Q3 2025 earnings call highlights, showcasing strong growth in its cardiac and neuromodulation segments....


ABTJanuary 2, 2025Abbott Laboratories: A Promising Stock with Strong Fundamentals  ~2 min.

Abbott Laboratories (NYSE:ABT) is catching the attention of investors, including Diamond Hill Capital, as one of their top stock picks....


FORDDecember 24, 2024FORD FORWARD INDUSTRIES, INC. Announces Exciting Partnership and Launch of Revolutionary Technology for Stroke and Spinal Cord Injury  ~2 min.

Neuvotion, a leading medical device company, has recently expanded its partnership with Intelligent Product Solutions (IPS) and successfully commercialized its innovative NeuStim technology....


ABTDecember 3, 2024Abbott Laboratories Develops New Breakthrough in Medical Technology  ~2 min.

Abbott Laboratories, a leading global healthcare company, has announced a groundbreaking innovation in medical technology....